Virologic outcomes with tenofovir-lamivudine-dolutegravir in adults failing PI-based second-line ART
Background: In South African antiretroviral guidelines, selected patients failing second-line protease inhibitor (PI)-based therapy qualify for genotypic resistance testing - those with PI resistance receive darunavir-based third-line regimens; those without PI resistance continue current regimen wi...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | Book |
Published: |
AOSIS,
2024-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!